A Glowing Result

Induced cellular events distinguished by LumiTech's ApoGlow assay Apoptosis is an organized, energy-dependent process involving a number of well-defined pathways that lead to the death of a cell. Ultimately, these pathways converge on the mitochondria, causing changes in mitochondrial transmembrane potential that perturb cellular ADP:ATP ratios. Scientists at LumiTech Ltd. of Nottingham, United Kingdom, have shown that distinctive changes in the ADP:ATP ratio occur during cellular apoptosis and

Written byBarbara Cunningham
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share


Induced cellular events distinguished by LumiTech's ApoGlow assay
Apoptosis is an organized, energy-dependent process involving a number of well-defined pathways that lead to the death of a cell. Ultimately, these pathways converge on the mitochondria, causing changes in mitochondrial transmembrane potential that perturb cellular ADP:ATP ratios. Scientists at LumiTech Ltd. of Nottingham, United Kingdom, have shown that distinctive changes in the ADP:ATP ratio occur during cellular apoptosis and necrosis, enabling discrimination between these cellular states.1 LumiTech's new ApoGlow kit uses bioluminescent detection of adenylate nucleotides to monitor changes in the cellular ratio of ADP:ATP. According to Kevin Slater, managing director at LumiTech, it is now possible to determine all possible results from putative cell viability-affecting agents within a single test.

In this system, cells are grown in 96-well microplates. Plates can be loaded directly from the incubator into the luminometer, which measures the intensity of light emitted following luciferase catalysis, ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies